Medical News

Surgery

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Filipponi F et al. – Standard–dose intramuscular Igantibe administration proved efficacious in post–liver transplantation prophylaxis by attaining protective levels for up to 6 months, was safe and well tolerated. Pharmacokinetic analysis revealed a long half–life and extensive exposure.

Related Articles

Hepatitis B does not increase risk for pancreatic cancer
EurekAlert, 11/02/09    Relevance Score: 70%

Reactivation of Hepatitis B With Reappearance of Hepatitis B Surface Antigen After Chemotherapy and Immunosuppression
Clinical Gastroenterology and Hepatology, 10/09/09    Relevance Score: 70%

Age-specific prognosis following spontaneous hepatitis B e antigen seroconversion in chronic hepatitis B
Hepatology, 11/18/09    Relevance Score: 69%

Liver enzyme abnormalities in systemic lupus erythematosus: A focus on toxic hepatitis
Rheumatology International, 11/13/09    Relevance Score: 69%

Hepatitis B Virus Resistance to Nucleostide Analogues
Gastroenterology, 10/28/09    Relevance Score: 69%

Today in Transplantation...keeping you current

Post-transplant lymphoproliferative disorder localized in the colon after liver transplantation: Report of a case
Surgery Today, 12/18/09

Survival impact of lung transplantation for chronic obstructive pulmonary disease
European Respiratory Journal , 12/17/09

Effect of Liver Transplantation on Spleen Size, Collateral Veins, and Platelet Counts
World Journal of Surgery, 12/16/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address